Disease-specific quality indicators, guidelines and outcome measures
Management guidelines and outcome measures in giant cell arteritis (GCA)
K.J. Warrington, E.L. Matteson
CER3125
2007 Vol.25, N°6 ,Suppl.47
PI 0137, PF 0141
Disease-specific quality indicators, guidelines and outcome measures
Free to view
(click on article PDF icon to read the article)
PMID: 18021519 [PubMed]
Abstract
ABSTRACT: Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the condition and the diagnosis is usually established by temporal artery biopsy. Corticosteroids are the mainstay of treatment for GCA and prolonged therapy is often necessary. Disease relapses and steroid-related adverse effects, however, are common. Serious complications of the disease may include visual loss, stroke, and aortic involvement with aneurysm formation.
